Manoj Malhotra Selected Research

perampanel

5/2022	Perampanel in real-world clinical care of adolescent and adult patients with epilepsy: Results from the retrospective Phase IV PROVE Study.
1/2022	A post-approval observational study to evaluate the safety and tolerability of perampanel as an add-on therapy in adolescent, adult, and elderly patients with epilepsy.
1/2022	PROVE: Retrospective, non-interventional, Phase IV study of perampanel in real-world clinical care of patients with epilepsy.
1/2022	PROVE-Phase IV Study of Perampanel in Real-World Clinical Care of Patients with Epilepsy: Interim Analysis in Pediatric Patients.
1/2022	Sustained seizure freedom with adjunctive perampanel in patients with convulsive seizures: Post hoc analysis of open-label extension studies 307 and 332.
1/2022	Long-term open-label perampanel: Generalized tonic-clonic seizures in idiopathic generalized epilepsy.
12/2021	Real-world analysis of hospitalizations in patients with epilepsy and treated with perampanel.
1/2021	Efficacy, safety, and tolerability of adjunctive perampanel in patients from China with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of phase III double-blind and open-label extension studies.
1/2021	Real-world impact of antiepileptic drug combinations with versus without perampanel on healthcare resource utilization in patients with epilepsy in the United States.
1/2021	Efficacy and safety of adjunctive perampanel in patients with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of Phase II and Phase III double-blind and open-label extension studies in India.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manoj Malhotra Research Topics

Disease

14	Seizures (Absence Seizure) 01/2022 - 06/2019
10	Epilepsy (Aura) 05/2022 - 01/2020
5	Dizziness (Lightheadedness) 01/2022 - 01/2020
3	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2022 - 01/2022
2	Drug Resistant Epilepsy 01/2022 - 01/2021
2	Sleepiness 01/2022 - 01/2020
2	Idiopathic Generalized Epilepsy 01/2022 - 08/2020
2	Lennox Gastaut Syndrome 09/2021 - 06/2019
1	Fatigue 04/2022
1	Ataxia (Dyssynergia) 01/2022
1	Weight Gain 01/2022
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Headache (Headaches) 01/2020
1	Nasopharyngitis 01/2020

Drug/Important Bio-Agent (IBA)

16	perampanelIBA 05/2022 - 01/2020
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 01/2020
2	lemborexantIBA 04/2022 - 01/2022
2	rufinamide FDA Link 09/2021 - 06/2019
2	Pharmaceutical PreparationsIBA 01/2021 - 06/2019
1	Orexin Receptor AntagonistsIBA 04/2022
1	Contraceptive Agents (Contraceptives)IBA 01/2022
1	Trazodone (Trittico)FDA LinkGeneric 01/2022
1	Levonorgestrel (Plan B)FDA LinkGeneric 01/2022
1	BenzodiazepinesIBA 01/2022
1	Zolpidem (Ambien)FDA LinkGeneric 01/2022
1	Lacosamide FDA Link 12/2021
1	Immunoglobulin E (IgE)IBA 08/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020

Therapy/Procedure

1	Therapeutics 01/2022